Buy and Bill explained
Buy and bill gives practices control over drug supply and timing, but the practice carries the financial risk of denials, underpayments, and price changes.
Strong authorization, unit accuracy, and payment monitoring are essential, because a single denied infusion can cost the practice thousands of dollars in drug cost.
Where Buy and Bill fits in the revenue cycle
Buy and Bill sits within the specialty-specific layer of the revenue cycle. It is a specialty billing concept, a rule or workflow that applies to a particular clinical specialty's claims.
You'll encounter Buy and Bill on payer communications, billing reports, and in conversations between front-office, coding, and accounts-receivable teams.
Why Buy and Bill matters for your practice
Specialty practices live and die by rules that generic billing systems were never built to handle, drug waste billing, global surgical periods, infusion scheduling, and more. Mastering specialty-specific terminology is what separates practices that capture every earned dollar from those that quietly leak revenue.
- Applies specialty-specific rules to coding and billing
- Generic billing platforms often miss these nuances
- Directly tied to revenue capture in specialty practices
- Examples span oncology, infusion, surgery, and more
Buy and Bill in practice
Knowing what Buy and Bill means is only useful if it changes what your team does. In a modern revenue cycle, that means catching issues related to specialty Billing earlier, documenting and coding them correctly, and using technology to flag exceptions automatically rather than discovering them after a claim is denied.
This is exactly where a specialty-built revenue cycle platform earns its keep: by encoding the rules behind terms like Buy and Bill directly into the workflow, so clean claims go out the first time and your team works by exception instead of chasing problems after the fact.
